What sector is DMAAR in?

Financials, in the Blank Checks industry.

NASDAQ · DMAARFinancialsBlank Checks

Drugs Made In America Acquisition Corp. Rights (DMAAR)

$0.1249−0.08%

Close Sep 28, 2026 · split-adjusted

Sep 28, 2026$0.12▼ 43.25% in range

Sep 29, 2025Low $0.04 · High $0.23Sep 28, 2026

What changed · written from our data

As of Sep 28, 2026

Drugs Made In America Acquisition Corp. Rights closed at $0.12 on Sep 28, down 0.08%, 45.7% below its highest close since Feb 25. Volume of 785 shares was 0.01× its 20-day average (below normal).

Split-adjusted performance: -10.8% over one month, +165.2% over six months.

Short interest was 88.6K shares at the Sep 15 settlement, down 49.3% from the prior report (1.7 days to cover).

Market cap—

Revenue · quarter$0.00—

Diluted EPS$0.06−14.3% YoY

P/E · TTM—

Net margin—

Dividend yieldNone

Range since Feb 250.04 – 0.23−45.7% from high

Volume7850.01× 20-day avg

Volatility · 60d126.5%Annualised

Short % of float—1.7 days to cover

Net cash-$329.7KCash $20.3K

Next earnings—Not scheduled

Split-adjusted performance

1W −1.2%1M −10.8%3M +19.0%6M +165.2%YTD −33.3%1Y —3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Blank Checks

Percentile among 165 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return +2.1%, revenue growth −2.0%, net margin −34.2%, P/E 43.1×.

Short interest

Details →

Shares short88.6K−49.3% vs prior

Days to cover1.7Settled Sep 15

% of float—

Short vol. 10d35.3%of daily volume

News about Drugs Made In America Acquisition Corp. Rights

All news →

No recent articles focused on Drugs Made In America Acquisition Corp. Rights.

Quick answers

What sector is DMAAR in?: Financials, in the Blank Checks industry.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology